This conference highlights presentations from LE&RN's designated Comprehensive and Network Centers of Excellence.
The Centers of Excellence 2020 Summit: State-of-the-Art Lymphatic Medicine is hosted by Stanford University School of Medicine and LE&RN. It is chaired by Stanley G. Rockson, M.D., the Allan and Tina Neill Professor of Lymphatic Research and Medicine at Stanford University.
Upon completion of this activity, participants will be able to:
- Utilize tools to achieve a diagnosis and differential diagnosis of lymphatic disease
- Recommended treatment options and interventions for patients with lymphatic disease
- Identify appropriate patients to refer for surgical interventions for lymphatic disease
Lymphatic research has led to a rapidly emerging and expanding clinical discipline with newly established standards for Centers of Excellence in Lymphatic Medicine. Up to 10 million Americans are estimated to be living with lymphedema and there are an additional 17 million women in America estimated to have lipedema. Nevertheless, lymphatic patients still struggle to find physicians who are prepared to undertake their necessary medical care. Upon completion of this summit, participants will attain comfort in the diagnosis and differential diagnosis of lymphedema, lipedema, and a variety of lymphatic vascular malformations and will acquire the skills necessary to make vital medical and surgical therapeutic decisions for these patients.
Stanley G. Rockson, MD
Summit Organizer Chief of Consultative Cardiology, Allan and Tina Neill Professor of Lymphatic Research and Medicine Professor of Medicine, Director, Center for Lymphatic and Venous Disorders Stanford University School of Medicine, Falk Cardiovascular Research Center
Speakers
- Melissa Aldrich, University of Texas Health Science Center at Houston, TX
- Kathy Bates, LE&RN Spokesperson, Academy Award Winner
- David Chang, University of Chicago Medicine, Chicago, IL
- Joseph Dayan, Memorial Sloan Kettering Cancer Center, New York, NY
- Sudhen Desai, Texas Children’s Hospital, Houston, TX
- Yoav Dori, Children’s Hospital of Philadelphia, PA
- Kristiana Gordon, St. George’s University Hospitals—National Lymphoedema Clinic, London, UK
- Vaughan Keeley, Derby Lymphoedema Service, Royal Derby Hospital, Derby, UK
- Alan Kimmel, Greater Baltimore Medical Center, Baltimore, MD
- Louise Koelmeyer, Australian Lymphoedema Education Research and Treatment (ALERT) Program, Macquarie University, NSW, Australia
- Alison Nauta, Oregon Health and Science University and Doernbecher Children's Hospital, Portland, OR
- Peter Neligan, University of Washington, Seattle, WA
- Ketan Patel, Keck USC School of Medicine, Los Angeles, CA
- Isabelle Quere, CHU Montpellier, Montpellier, France
- William Repicci, CEO and President, LE&RN, New York, NY
- Stanley G. Rockson, Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, Palo Alto, CA
- Dhruv Singhal, The Lymphatic Center at Beth Israel Deaconess Medical Center, Boston, MA
- Roman Skoracki, The Ohio State University Comprehensive Cancer Center, Columbus, OH
Curriculum
Stanley G. Rockson, Stanford University, Palo Alto, CA and LE&RN, New York, NY
William Repicci, CEO and President, LE&RN, New York, NY
Kathy Bates, LE&RN Spokesperson
Melissa Aldrich, University of Texas Health Science Center at Houston, TX
Ketan Patel, Keck USC School of Medicine, Los Angeles, CA
Roman Skoracki, The Ohio State University Comprehensive Cancer Center, Columbus, OH
Stanley G. Rockson, Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, Palo Alto, CA
Dhruv Singhal, The Lymphatic Center at Beth Israel Deaconess Medical Center, Boston, MA
David Chang, University of Chicago Medicine, Chicago, IL
Joseph Dayan, Memorial Sloan Kettering Cancer Center, New York, NY
Peter Neligan, University of Washington, Seattle, WA
Kristiana Gordon, St. George’s University Hospitals—National Lymphoedema Clinic, London, UK
Sudhen Desai, Texas Children’s Hospital, Houston, TX
Yoav Dori, Children’s Hospital of Philadelphia, PA
Isabelle Quere, CHU Montpellier, Montpellier, France
Alan Kimmel, Greater Baltimore Medical Center, Baltimore, MD
Alison Nauta, Oregon Health and Science University and Doernbecher Children's Hospital, Portland, OR
Vaughan Keeley, Derby Lymphoedema Service, Derby, UK
Louise Koelmeyer, Australian Lymphoedema Education Research and Treatment (ALERT) Program, Macquarie University, NSW, Australia
Presenting Sponsors:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning and LE&RN. ACHL is accredited by the ACCME to provide continuing medical education for physicians.
The Academy for Continued Healthcare Learning designates this enduring material for up to 8.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Guidelines require that participants in CME activities be made aware of all financial relationships that may be perceived as affecting the presentation of the faculty member. ACHL ensures that all faculty and staff involved in the planning, development, and implementation of ACHL activities disclose relevant financial relationships and that conflicts of interest are resolved before the CME activity occurs. Complete information will be provided to participants prior to the start of the educational activity.